These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma. Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423 [TBL] [Abstract][Full Text] [Related]
8. Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children. Anderson RC; Kennedy B; Yanes CL; Garvin J; Needle M; Canoll P; Feldstein NA; Bruce JN J Neurosurg Pediatr; 2013 Mar; 11(3):289-95. PubMed ID: 23240851 [TBL] [Abstract][Full Text] [Related]
9. Influence of an intratumoral cyst on drug distribution by convection-enhanced delivery: case report. Ivasyk I; Morgenstern PF; Wembacher-Schroeder E; Souweidane MM J Neurosurg Pediatr; 2017 Sep; 20(3):256-260. PubMed ID: 28686124 [TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts. Sugiyama S; Yamashita Y; Kikuchi T; Sonoda Y; Kumabe T; Tominaga T Neurol Res; 2008 Nov; 30(9):960-7. PubMed ID: 18671903 [TBL] [Abstract][Full Text] [Related]
11. Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model. Saito R; Bringas JR; Panner A; Tamas M; Pieper RO; Berger MS; Bankiewicz KS Cancer Res; 2004 Oct; 64(19):6858-62. PubMed ID: 15466173 [TBL] [Abstract][Full Text] [Related]
12. Controlled release of liposome-encapsulated temozolomide for brain tumour treatment by convection-enhanced delivery. Lin CY; Li RJ; Huang CY; Wei KC; Chen PY J Drug Target; 2018 Apr; 26(4):325-332. PubMed ID: 28911239 [TBL] [Abstract][Full Text] [Related]
13. The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery. Singleton WGB; Bienemann AS; Woolley M; Johnson D; Lewis O; Wyatt MJ; Damment SJP; Boulter LJ; Killick-Cole CL; Asby DJ; Gill SS J Neurosurg Pediatr; 2018 Sep; 22(3):288-296. PubMed ID: 29856296 [TBL] [Abstract][Full Text] [Related]
14. Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas. Enríquez Pérez J; Kopecky J; Visse E; Darabi A; Siesjö P BMC Cancer; 2020 Jan; 20(1):7. PubMed ID: 31900109 [TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic and therapeutic investigation of focused ultrasound-induced blood-brain barrier opening for enhanced temozolomide delivery in glioma treatment. Liu HL; Huang CY; Chen JY; Wang HY; Chen PY; Wei KC PLoS One; 2014; 9(12):e114311. PubMed ID: 25490097 [TBL] [Abstract][Full Text] [Related]
16. In-vitro and in-vivo performance studies of a porous infusion catheter designed for intraparenchymal delivery of therapeutic agents of varying size. Brady ML; Grondin R; Zhang Z; Pomerleau F; Powell D; Huettl P; Wilson M; Stice J; Gerhardt GA; Abramov V; Raghavan R J Neurosci Methods; 2022 Aug; 378():109643. PubMed ID: 35691412 [TBL] [Abstract][Full Text] [Related]